Coherus BioSciences Inc (CHRS)
1.51
-0.06
(-3.82%)
USD |
NASDAQ |
Jan 08, 16:00
1.47
-0.04
(-2.65%)
Pre-Market: 09:18
Coherus BioSciences Total Assets (Quarterly): 505.00M for Sept. 30, 2024
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Amgen Inc | 90.88B |
| Eli Lilly and Co | 75.61B |
| CEL-SCI Corp | 24.07M |
| AIM ImmunoTech Inc | 13.59M |
| IGC Pharma Inc | 10.37M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 592.97M |
| Shareholders Equity (Quarterly) | -87.97M |
| Debt to Equity Ratio | -3.007 |
| Current Ratio | 1.248 |
| Net Debt Paydown Yield | 34.67% |